Pluracidomycin C1

• Description :

  Pluracidomycin C1 is a carbapenem antibiotic. Pluracidomycin C1 has anti-Gram-positive bacteria and Gram-negative bacteria activity, and has the effect of inhibiting β-lactamase[1].

• UNSPSC :

  12352211

• Target :

  Antibiotic; Bacterial

• Related Pathways :

  Anti-infection

• Applications :

  COVID-19-immunoregulation

• Field of Research :

  Infection

• Smiles :

  O=S(O[C@H]([C@@]1([H])[C@]2([H])N(C1=O)C(C(O)=O)=C(C2)S(C(O)O)=O)C)(O)=O

• Molecular Formula :

  C10H13NO10S2

• Molecular Weight :

  371.34

• References & Citations :

  [1]T Yoshida, et al. Therapeutic effect of SF-2103A, a novel carbapenem antibiotic, in combination with cefotaxime, cefoperazone and other cephalosporins. J Antibiot (Tokyo) . 1986 Jul;39 (7) :956-65.

• Shipping Conditions :

  Room temperature

• Scientific Category :

  Natural Products

• Clinical Information :

  No Development Reported

• CAS Number :

  [82138-66-7]